INTEGER HOLDINGS CORPORATION Business Acquisition, Pro Forma Revenue
INTEGER HOLDINGS CORPORATION (ITGR) reported Business Acquisition, Pro Forma Revenue of $10.60 million for the 3-month period ending 2024-03-29, per its 10-Q filed 2024-04-25.
Financial Statements › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2024-10-24
- INTEGER HOLDINGS CORPORATION business acquisition, pro forma revenue for the quarter ending 2024-03-29 was $10.60M.
- INTEGER HOLDINGS CORPORATION business acquisition, pro forma revenue for the quarter ending 2023-12-31 was $414.05M.
- INTEGER HOLDINGS CORPORATION business acquisition, pro forma revenue for the quarter ending 2023-09-29 was $414.69M.
- INTEGER HOLDINGS CORPORATION business acquisition, pro forma revenue for the quarter ending 2023-06-30 was $415.84M.
- INTEGER HOLDINGS CORPORATION business acquisition, pro forma revenue for fiscal 2023 was $1.62B, a 15.19% increase from fiscal 2022.
- INTEGER HOLDINGS CORPORATION business acquisition, pro forma revenue for fiscal 2022 was $1.40B, a 8.59% increase from fiscal 2021.
- INTEGER HOLDINGS CORPORATION business acquisition, pro forma revenue for fiscal 2021 was $1.29B.
- INTEGER HOLDINGS CORPORATION business acquisition, pro forma revenue for fiscal 2016 was $1.45B, a 0.27% increase from fiscal 2015.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 6 month | Business Acquisition, Pro Forma Revenue 9 month | Business Acquisition, Pro Forma Revenue 12 month | Business Acquisition, Pro Forma Revenue 12 month as first filed |
|---|---|---|---|---|---|
| 2024-03-29 | $10.60M 10-Q · filed 2024-04-25 | $424.65M derived: sum of 2 quarters · filed 2024-04-25 | $839.34M derived: sum of 3 quarters · filed 2024-10-24 | $1.26B derived: sum of 4 quarters · filed 2024-10-24 | |
| 2023-12-31 | $414.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $828.74M derived: sum of 2 quarters · filed 2024-10-24 | $1.24B derived: sum of 3 quarters · filed 2024-10-24 | $1.62B 10-K · filed 2024-02-20 | |
| 2023-09-29 | $414.69M 10-Q · filed 2024-10-24 | $830.52M derived: sum of 2 quarters · filed 2024-10-24 | $1.20B 10-Q · filed 2024-10-24 | ||
| 2023-06-30 | $415.84M 10-Q · filed 2024-07-25 | $811.35M 10-Q · filed 2024-07-25 | |||
| 2022-12-31 | $1.40B 10-K · filed 2024-02-20 | ||||
| 2021-12-31 | $1.29B 10-K · filed 2024-02-20 | ||||
| 2016-04-01 | $332.24M 10-Q · filed 2016-05-10 | $692.01M derived: sum of 2 quarters · filed 2017-02-28 | $1.04B derived: sum of 3 quarters · filed 2017-02-28 | $1.42B derived: sum of 4 quarters · filed 2017-02-28 | |
| 2016-01-01 | $359.78M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $709.34M derived: sum of 2 quarters · filed 2017-02-28 | $1.09B derived: sum of 3 quarters · filed 2017-02-28 | $1.45B 10-K · filed 2017-02-28 | |
| 2015-10-02 | $349.56M 10-Q · filed 2016-11-08 | $727.50M derived: sum of 2 quarters · filed 2016-11-08 | $1.09B 10-Q · filed 2016-11-08 | ||
| 2015-07-03 | $377.93M 10-Q · filed 2016-08-09 | $736.35M 10-Q · filed 2016-08-09 | |||
| 2015-04-03 | $358.42M 10-Q · filed 2016-05-10 | ||||
| 2015-01-02 | $1.44B 10-K · filed 2017-02-28 | $696.36M 10-K · filed 2015-03-03 | |||
| 2014-01-03 | $190.33M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01 | $358.06M derived: sum of 2 quarters · filed 2016-03-01 | $529.39M derived: sum of 3 quarters · filed 2016-03-01 | $677.66M 10-K · filed 2016-03-01 | |
| 2013-09-27 | $167.73M 10-Q · filed 2013-11-05 | $339.06M derived: sum of 2 quarters · filed 2013-11-05 | $487.33M 10-Q · filed 2013-11-05 | $646.51M derived: sum of 4 quarters · filed 2015-03-03 | |
| 2013-06-28 | $171.33M 10-Q · filed 2013-08-06 | $319.60M 10-Q · filed 2013-08-06 | $478.78M derived: sum of 3 quarters · filed 2015-03-03 | $640.12M derived: sum of 4 quarters · filed 2015-03-03 | |
| 2013-03-29 | $148.26M 10-Q · filed 2013-05-07 | $307.45M derived: sum of 2 quarters · filed 2015-03-03 | $468.79M derived: sum of 3 quarters · filed 2015-03-03 | $635.34M derived: sum of 4 quarters · filed 2015-03-03 | |
| 2012-12-28 | $159.19M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | $320.53M derived: sum of 2 quarters · filed 2015-03-03 | $487.07M derived: sum of 3 quarters · filed 2015-03-03 | $646.62M 10-K · filed 2015-03-03 | |
| 2012-09-28 | $161.34M 10-Q · filed 2013-11-05 | $327.89M derived: sum of 2 quarters · filed 2013-11-05 | $487.43M 10-Q · filed 2013-11-05 | $645.77M derived: sum of 4 quarters · filed 2014-03-04 | |
| 2012-06-29 | $166.55M 10-Q · filed 2013-08-06 | $326.09M 10-Q · filed 2013-08-06 | $484.43M derived: sum of 3 quarters · filed 2014-03-04 | $634.42M derived: sum of 4 quarters · filed 2014-03-04 | |
| 2012-03-30 | $159.54M 10-Q · filed 2013-05-07 | $317.89M derived: sum of 2 quarters · filed 2014-03-04 | $467.88M derived: sum of 3 quarters · filed 2014-03-04 | $631.49M derived: sum of 4 quarters · filed 2014-03-04 | |
| 2011-12-30 | $158.34M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-04 | $308.33M derived: sum of 2 quarters · filed 2014-03-04 | $471.95M derived: sum of 3 quarters · filed 2014-03-04 | $636.50M 10-K · filed 2014-03-04 | |
| 2011-09-30 | $149.99M 10-Q · filed 2012-11-06 | $313.60M derived: sum of 2 quarters · filed 2012-11-06 | $478.16M 10-Q · filed 2012-11-06 | ||
| 2011-07-01 | $163.61M 10-Q · filed 2012-08-07 | $328.17M 10-Q · filed 2012-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |